Zou C - Search Results

1

Molecular profiling identifies distinct subtypes across TP53 mutant tumors.

Chen X, Liu T, Wu J, Zhu C, Guan G, Zou C, Guo Q, Ren X, Li C, Cheng P, Cheng W, Wu A. Chen X, et al. Among authors: zou c. JCI Insight. 2022 Dec 8;7(23):e156485. doi: 10.1172/jci.insight.156485. JCI Insight. 2022. PMID: 36256461 Free PMC article.

2

Gremlin1 promotes carcinogenesis of glioma in vitro.

Guan Y, Cheng W, Zou C, Wang T, Cao Z. Guan Y, et al. Among authors: zou c. Clin Exp Pharmacol Physiol. 2017 Feb;44(2):244-256. doi: 10.1111/1440-1681.12697. Clin Exp Pharmacol Physiol. 2017. PMID: 27862197

3

Primary Extradural Melanoma Arising in Cervical Spinal Nerve Root.

Zou C, Cheng W, Zhu C, Guo Q, Wu A. Zou C, et al. World Neurosurg. 2018 Mar;111:211-215. doi: 10.1016/j.wneu.2017.12.117. Epub 2017 Dec 27. World Neurosurg. 2018. PMID: 29288844

4

Costimulatory checkpoint SLAMF8 is an independent prognosis factor in glioma.

Zou CY, Guan GF, Zhu C, Liu TQ, Guo Q, Cheng W, Wu AH. Zou CY, et al. CNS Neurosci Ther. 2019 Mar;25(3):333-342. doi: 10.1111/cns.13041. Epub 2018 Aug 13. CNS Neurosci Ther. 2019. PMID: 30105842 Free PMC article.

5

Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.

Guo Q, Guan GF, Cheng W, Zou CY, Zhu C, Cheng P, Wu AH. Guo Q, et al. Among authors: zou cy. CNS Neurosci Ther. 2019 Mar;25(3):343-354. doi: 10.1111/cns.13072. Epub 2018 Oct 11. CNS Neurosci Ther. 2019. PMID: 30311408 Free PMC article.

6

Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.

Guo Q, Guan GF, Cao JY, Zou CY, Zhu C, Cheng W, Xu XY, Lin ZG, Cheng P, Wu AH. Guo Q, et al. Among authors: zou cy. J Cell Physiol. 2019 Sep;234(9):15496-15509. doi: 10.1002/jcp.28197. Epub 2019 Jan 28. J Cell Physiol. 2019. PMID: 30693511

7

CD48 is a key molecule of immunomodulation affecting prognosis in glioma.

Zou C, Zhu C, Guan G, Guo Q, Liu T, Shen S, Yan Z, Xu X, Lin Z, Chen L, Wu A, Cheng W. Zou C, et al. Onco Targets Ther. 2019 May 28;12:4181-4193. doi: 10.2147/OTT.S198762. eCollection 2019. Onco Targets Ther. 2019. PMID: 31213836 Free PMC article.

8

Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma.

Zhu C, Zou C, Guan G, Guo Q, Yan Z, Liu T, Shen S, Xu X, Chen C, Lin Z, Cheng W, Wu A. Zhu C, et al. Among authors: zou c. Oncoimmunology. 2019 Jun 12;8(9):e1621677. doi: 10.1080/2162402X.2019.1621677. eCollection 2019. Oncoimmunology. 2019. PMID: 31428519 Free PMC article.

9

Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.

Cao JY, Guo Q, Guan GF, Zhu C, Zou CY, Zhang LY, Cheng W, Wang GL, Cheng P, Wu AH, Li GY. Cao JY, et al. Among authors: zou cy. Aging (Albany NY). 2020 Jan 29;12(2):1656-1684. doi: 10.18632/aging.102706. Epub 2020 Jan 29. Aging (Albany NY). 2020. PMID: 32003759 Free PMC article.

10

IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.

Zhu C, Chen X, Guan G, Zou C, Guo Q, Cheng P, Cheng W, Wu A. Zhu C, et al. Among authors: zou c. Onco Targets Ther. 2020 Feb 5;13:1129-1143. doi: 10.2147/OTT.S237162. eCollection 2020. Onco Targets Ther. 2020. PMID: 32103982 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,174 results

Search Page

Filters